US Markets
SPX

S&P 500, Nasdaq open at new highs on COVID-19 treatment hopes

Credit: REUTERS/BRENDAN MCDERMID

The S&P 500 and Nasdaq opened at record levels on Monday after the U.S. health regulator approved the emergency use of blood plasma in COVID-19 patients and on report the Trump administration may fast-track a vaccine candidate.

Aug 24 (Reuters) - The S&P 500 and Nasdaq opened at record levels on Monday after the U.S. health regulator approved the emergency use of blood plasma in COVID-19 patients and on report the Trump administration may fast-track a vaccine candidate.

The S&P 500 .SPX opened higher by 20.93 points, or 0.62%, at 3,418.09. The Nasdaq Composite .IXIC gained 137.45 points, or 1.22%, to 11,449.25 at the opening bell.

The Dow Jones Industrial Average .DJI rose 147.25 points, or 0.53%, at the open to 28,077.58.

(Reporting by Medha Singh in Bengaluru; Editing by Sriraj Kalluvila)

((Medha.Singh@thomsonreuters.com; within U.S. +1646 223 8780, outside U.S. +91 80 6749 1130; Twitter: https://twitter.com/medhasinghs))

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

SPX

Latest Markets Videos

Reuters

Reuters, the news and media division of Thomson Reuters, is the world’s largest international multimedia news provider reaching more than one billion people every day. Reuters provides trusted business, financial, national, and international news to professionals via Thomson Reuters desktops, the world's media organizations, and directly to consumers at Reuters.com and via Reuters TV.

Learn More